Production of hyperimmune serum against genotype VII Newcastle disease virus in rabbits with several applications

Authors

Keywords:

HI titer; hyperimmune serum; Newcastle disease

Abstract

Objective: This study aimed to produce hyperimmune serum against genotype VII Newcastle disease virus (NDV) with several applications. Materials and Methods: Production of hyperimmune serum against genotype VII NDV was performed on eight New Zealand white rabbits divided into four groups. Rabbits were immunized three times on the 1st day, the 14th day, and the 30th day. Blood sampling was carried out on the 8th day after the third immunization. Results: All groups showed the same pattern of hemagglutination inhibition (HI) titer results. HI titers would peak on the 5th or the 9th day after the second immunization, then decrease until the 3rd day after the third immunization, and increase again on the 5th day after the third immunization. Rabbits immunized intravenously showed higher HI titers than the other groups. These results indicate that the intravenous route for hyperimmune serum production against genotype VII Newcastle disease virus greatly affects the immune response result. Conclusions: The production of hyperimmune serum by intravenous immunization three times was able to produce the highest titer of 210 at 38 days. The agar gel precipitation test and the Western blot assay showed that the hyperimmune serum was specific for the Newcastle disease antigen.

J. Adv. Vet. Anim. Res., 9(2): 211–220, June 2022

http://doi.org/10.5455/javar.2022.i586

Downloads

Abstract
10
PDF
8

Downloads

Published

2022-06-26

How to Cite

Putri, D. D., Poetri, O. N., Candra, A. A., & Soejoedono, R. D. (2022). Production of hyperimmune serum against genotype VII Newcastle disease virus in rabbits with several applications. Journal of Advanced Veterinary and Animal Research, 9(2), 211–220. Retrieved from https://www.banglajol.info/index.php/JAVAR/article/view/80076

Issue

Vol. 9 No. 2 (2022)

Section

Original Articles

License

Copyright (c) 2022 Dwi Desmiyeni Putri, Okti Nadia Poetri, Agung Adi Candra, Retno Damajanti Soejoedono

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).